Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-1.01
↑ 73% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-3.79
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -1.01 | +70.1% |
| 2024 | -3.39 | +60.4% |
| 2023 | -8.55 | -292.0% |
| 2022 | -2.18 | -201.2% |
| 2021 | -0.72 | +93.2% |
| 2020 | -10.71 | - |
| 2019 | 0.00 | - |